Clinical trial
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in…
NCT00002653 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002653 |
|---|---|
| Title | Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma |
| Official title | VIIITH MYELOMATOSIS TRIAL: A RANDOMISED TRIAL OF TREATMENT FOR INDUCING FIRST PLATEAU PHASE ABCM VS 3 COURSES OF ABCM FOLLOWED BY ORAL WEEKLY CYCLOPHOSPHAMIDE |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Drug, Radiation |
| Interventions | carmustine, cyclophosphamide, doxorubicin hydrochloride, melphalan, prednisone, radiation therapy |
| Enrollment | 1,000 |
| Start date | Sep 1, 1993 |
| First posted | Apr 10, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: